We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-16.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$11.7B
AUM Growth
-$2.52B
(-18%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
289
New
40
Increased
99
Reduced
91
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$204M |
| 2 |
McDonald's
MCD
|
+$105M |
| 3 |
IBM
IBM
|
+$98M |
| 4 |
Bank of America
BAC
|
+$96.5M |
| 5 |
Broadcom
AVGO
|
+$74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$232M |
| 2 |
Wells Fargo
WFC
|
+$98.7M |
| 3 |
CME Group
CME
|
+$93.9M |
| 4 |
Celanese
CE
|
+$92.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$90.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.14% |
| 2 | Healthcare | 17.2% |
| 3 | Industrials | 12.75% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
CME Group
CME
$95B
| $14.2M | 0.12% |
75,737
-508,744
| -87% | -$93.9M |
|
177
Fate Therapeutics
FATE
$290M
| $14.2M | 0.12% |
1,104,305
+272,235
| +33% | +$3.8M |
|
|
IPHI
178
DELISTED
INPHI CORPORATION
IPHI
| $13.3M | 0.11% |
414,870
+240,880
| +138% | +$8.36M |
|
|
PR
179
Permian Resources
PR
$17B
| $13.3M | 0.11% |
1,209,310
-283,160
| -19% | -$4.86M |
|
180
Hamilton Lane
HLNE
$5.43B
| $13.2M | 0.11% |
357,732
-185,513
| -34% | -$6.94M |
|
181
MKS Inc
MKSI
$19.7B
| $12.3M | 0.11% |
190,652
-112,199
| -37% | -$8.11M |
|
182
Evolent Health
EVH
$404M
| $12.2M | 0.1% |
610,450
+193,470
| +46% | +$4.48M |
|
|
SMAR
183
DELISTED
Smartsheet Inc.
SMAR
| $12.1M | 0.1% |
+486,968
| New | +$12.1M |
|
|
CORV
184
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $11.8M | 0.1% |
4,737,804
-36,345
| -0.8% | -$121K |
|
185
Alarm.com
ALRM
$2.78B
| $11.5M | 0.1% |
221,813
-151,947
| -41% | -$7.34M |
|
|
CTLT
186
DELISTED
CATALENT, INC.
CTLT
| $10.8M | 0.09% |
347,301
-570,715
| -62% | -$22M |
|
187
Neurocrine Biosciences
NBIX
$16.2B
| $10.3M | 0.09% |
+143,740
| New | +$13.8M |
|
|
APLS
188
DELISTED
Apellis Pharmaceuticals
APLS
| $10.1M | 0.09% |
767,876
+155,580
| +25% | +$2.39M |
|
189
Abbott
ABT
$187B
| $10.1M | 0.09% |
139,150
-1,070
| -0.8% | -$75.2K |
|
190
National Vision
EYE
$1.8B
| $9.83M | 0.08% |
349,040
-125,585
| -26% | -$4.78M |
|
|
UCTT
191
Ultra Clean Holdings
UCTT
$3.76B
| $9.81M | 0.08% |
1,157,993
+146,295
| +14% | +$1.43M |
|
192
Walmart Inc
WMT
$892B
| $9.17M | 0.08% |
295,305
-2,340
| -0.8% | -$75K |
|
193
Commault Systems
CVLT
$5.53B
| $8.87M | 0.08% |
150,071
-454,146
| -75% | -$26.8M |
|
|
CBAY
194
DELISTED
Cymabay Therapeutics
CBAY
| $8.47M | 0.07% |
1,076,215
+166,835
| +18% | +$1.59M |
|
195
Matsons
MATX
$6.17B
| $8.45M | 0.07% |
+264,020
| New | +$9.77M |
|
196
Merck
MRK
$317B
| $7.88M | 0.07% |
108,142
-765
| -0.7% | -$54K |
|
197
Verizon
VZ
$195B
| $7.84M | 0.07% |
139,525
-1,110
| -0.8% | -$63K |
|
198
Advanced Energy
AEIS
$13B
| $7.43M | 0.06% |
173,030
-212,973
| -55% | -$9.49M |
|
199
Medtronic
MDT
$110B
| $7.2M | 0.06% |
79,205
+11,945
| +18% | +$1.12M |
|
200
Texas Instruments
TXN
$254B
| $7.17M | 0.06% |
75,835
-600
| -0.8% | -$58.1K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Westfield Capital Management held 289 positions worth $11.7B, down 18% from $14.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q4 2018 filing shows 40 new, 99 increased, 91 reduced and 49 closed positions. Its largest new stake was Marathon Petroleum: 2,982,907 shares worth $176M. The largest sale was Andeavor, an estimated $232M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2018 buy was Marathon Petroleum: 2,982,907 shares worth $176M.
- Westfield Capital Management added most to IBM in Q4 2018, an estimated $98M increase.
- Westfield Capital Management's biggest Q4 2018 reduction was CME Group, cutting an estimated $93.9M.
- Westfield Capital Management fully exited Andeavor in Q4 2018, selling an estimated $232M.
- Westfield Capital Management's ten largest holdings make up 19% of its $11.7B portfolio in Q4 2018.
- Westfield Capital Management opened 40 new positions and closed 49 in Q4 2018.
- Westfield Capital Management's portfolio value fell 18% quarter-over-quarter to $11.7B.
Based on Westfield Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.